A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A. Mayer, Georg A. Böhmig, Eva Schrezenmeier et al.|New England Journal of Medicine|2024Cited by 151
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international studyBruno Fattizzo, Wilma Barcellini, Bernd Jilma et al.|Haematologica|2020Cited by 66
LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 CellsSebastian Dörn, Bernd Jilma|BioResearch open access|2018Cited by 6
225.3: Randomized phase 2 trial of felzartamab in humoral transplant rejection.Katharina A. Mayer, Georg A. Böhmig, Eva Schrezenmeier et al.|Transplantation|2024Cited by 0